Marek Sanak - Selected Publications#

1. Wawrzyniak, P.; Krawczyk, K.; Acharya, S.; Tan, G.; Wawrzyniak, M.; Karouzakis, E.; Dreher, A.; Jakiela, B.; Altunbulakli, C.; Sanak, M.; O‘Mahony, L.; Nadeau, K.; Akdis, C. A., Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma. Allergy: European Journal of Allergy and Clinical Immunology 2021, 76 (6), 1864-1868.

2. Tyrak, K. E.; Pajdzik, K.; Jakieła, B.; Kupryś-Lipińska, I.; Ćmiel, A.; Kacorzyk, R.; Trąd, G.; Kuna, P.; Sanak, M.; Mastalerz, L., Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease. Clinical and Experimental Allergy 2021, 51 (8), 1046-1056.

3. Siemińska, I.; Węglarczyk, K.; Surmiak, M.; Kurowska-Baran, D.; Sanak, M.; Siedlar, M.; Baran, J., Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions. Frontiers in Immunology 2021, 12.

4. Karska-Basta, I.; Pociej-Marciak, W.; Chrząszcz, M.; Kubicka-Trząska, A.; Romanowska-Dixon, B.; Sanak, M., Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy. Acta Ophthalmologica 2021, 99 (2), e222-e231.

5. Pancer, K.; Milewska, A.; Owczarek, K.; Dabrowska, A.; Kowalski, M.; Labaj, P.; Branicki, W.; Sanak, M.; Pyrc, K., The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans. PLoS Pathogens 2020, 16 (12).

6. Milewska, A.; Kula-Pacurar, A.; Wadas, J.; Suder, A.; Szczepanski, A.; Dabrowska, A.; Owczarek, K.; Marcello, A.; Ochman, M.; Stacel, T.; Rajfur, Z.; Sanak, M.; Labaj, P.; Branicki, W.; Pyrc, K., Replication of severe acute respiratory syndrome coronavirus 2 in human respiratory epithelium. Journal of Virology 2020, 94 (15).

7. Bartoszewski, R.; Dabrowski, M.; Jakiela, B.; Matalon, S.; Harrod, K. S.; Sanak, M.; Collawn, J. F., SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs. American Journal of Physiology - Lung Cellular and Molecular Physiology 2020, 319 (3), L444-L455.

8. Mastalerz, L.; Tyrak, K. E.; Ignacak, M.; Konduracka, E.; Mejza, F.; Ćmiel, A.; Buczek, M.; Kot, A.; Oleś, K.; Sanak, M., Prostaglandin E2 decrease in induced sputum of hypersensitive asthmatics during oral challenge with aspirin. Allergy: European Journal of Allergy and Clinical Immunology 2019, 74 (5), 922-932.

9. Michalik, M.; Wójcik-Pszczoła, K.; Paw, M.; Wnuk, D.; Koczurkiewicz, P.; Sanak, M.; Pękala, E.; Madeja, Z., Fibroblast-to-myofibroblast transition in bronchial asthma. Cellular and Molecular Life Sciences 2018, 75 (21), 3943-3961.

10. Sierzega, M.; Kaczor, M.; Kolodziejczyk, P.; Kulig, J.; Sanak, M.; Richter, P., Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: The importance of MIR-21 and MIR-331. British Journal of Cancer 2017, 117 (2), 266-273.